Phthalocyanine induced phototherapy coupled with Doxorubicin; a promising novel treatment for breast cancer

References

• El-Hussein A, Harith M, Abrahamse H. Assessment of DNA damage after photodynamic therapy using a metallophthalocyanine photosensitizer. Int J Photoenergy. 2012;2012:1–10.
   Web of Science ®Google Scholar
• Klug S, Cummings R, Spencer A. et al., Concept of genetic. 10th ed. United State of America (USA): PearsonEducation Inc.; 2012. p. 474–578.
   Google Scholar
• Balmer CM, Valley AM. Cancer treatment and chemotherapy in pharmacotherapy; a pathophysiologic approach. 5th ed. United State of America (USA): McGraw-Hill Companies, Inc. 2002. p. 2200–2202. Dipiro JT, Talbert RL, Yee GC, et al.
   Google Scholar
• Hynek D, Krejcova L, Zitka O, et al. Electrochemical study of doxorubicin interaction with different sequences of single stranded oligonucleotides, part 1. Int J Electrochem Sc. 2012;7:13–33.
   Web of Science ®Google Scholar
• Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49:1374–1403.
   PubMed Web of Science ®Google Scholar
• Tynga IM, Houreld HH, Abrahamse H. The primary subcellular localization of zinc phthalocyanine and its cellular impact on viability, proliferation and structure of breast cancer cells (MCF-7). J Photochem Photobiol. 2013;120:171–176.
   Web of Science ®Google Scholar
• El-Hussein A, Tynga IM, Harith MA, et al. Comparative study between the photodynamic ability of gold and silver nanoparticles in mediating cell death in breast and lung cancer cell lines. J Photochem Photobiol. 2015;153:67–75.
   Web of Science ®Google Scholar
• American Cancer Society. Breast Cancer Facts and Figures 2013 to 2014. Atlanta: American Cancer Society, Inc. 2013. Available from http://www.cancer.org/acs/groups/cid/documents/webcontent/003037-pdf
   Google Scholar
• Jevaji IP, Clayton JA, Pinn VW. Research on the health effects of diethylstilbestrol. Bethesda, Maryland: National Institute of Health; 2011.
   Google Scholar
• Titus-Ernstoff I, Hatch EE, Hoover RN, et al. Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy. Br J Cancer. 2001;84(1):126–133.
   PubMed Web of Science ®Google Scholar
• Marchio C, Reis-Filho JS. Molecular diagnosis in breast cancer. Diagn Histopathol. 2008;14(5):202–213.
   Google Scholar
• Tobias J, Hochhanser D. Breast cancer in cancer and its management. 7th ed. United Kingdom (UK): John Wiley and Sons. 2015. p. 237–274.
   Google Scholar
• Chew HK. Adjuvant therapy for breast cancer: who should get what? West J Med. 2001;174:284–287.
   PubMedGoogle Scholar
• George B, Abrahamse H. A review on novel breast cancer therapies: photodynamic therapy and plant derived agent induced cell death mechanisms. Anticancer Agents Med Chem. 2016;16(7):793–801.
   PubMed Web of Science ®Google Scholar
• Turner N, Biganzoli L, Leo AD. Continued value of adjuvant anthracyclines as treatment for early breast cancer. Lancet Oncol. 2015;16:e362–e369.
   PubMed Web of Science ®Google Scholar
• Early breast cancer trialists’ collaborative group. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100000 women in 123 randomized trials. Lancet. 2012;379:432–444.
   PubMed Web of Science ®Google Scholar
• Mackey JR, Pienkowski T, Crown J, et al. Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial. Ann Oncol. 2016;27:1041–1047.
   PubMed Web of Science ®Google Scholar
• Marcinkowski EF, Ottesen R, Niland J, et al. Acceptance of adjuvant chemotherapy recommendations in early-stage hormone-positive breast cancer. J Surg Res. 2017;214:79–85.
   PubMedGoogle Scholar
• Tan C, Etcubanas E, Wollner N, et al. Adriamycin – an antitumor antibiotic in the treatment of neoplastic diseases. Cancer. 1973;32(1):9–17.
   PubMed Web of Science ®Google Scholar
• Howland RD, Mycek MJ. Pharmacology. Lippincott’s illustrated reviews 3rd ed. United State of America (USA): Lippincott Williams and Wilkins; 2006. p. 465–466.
   Google Scholar
• Mitry AM, Edwards GJ. Doxorubicin induced heart failure: phenotype and molecular mechanisms. Int J Cardiol Heart Vasc. 2016;10:17–24.
   PubMed Web of Science ®Google Scholar
• Octavia Y, Tocchetti CG, Gabrielson KL, et al. Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies. J Mol Cell Cardiol. 2012;52:1213–1225.
   PubMed Web of Science ®Google Scholar
• Yang F, Teves SS, Kemp JC, et al. Doxorubicin, DNA torsion and chromatin dynamics. Biochim Biophys Acta. 2014;1845:84–89.
   PubMed Web of Science ®Google Scholar
• Lou P, Lai P, Shieh M, et al. Reversal of doxorubicin resistance in breast cancer cells by photochemical internalization. Int J Cancer. 2006;119:2692–2698.
   PubMed Web of Science ®Google Scholar
• Hovorka O, Subr V, Vetvicka D, et al. Spectral analysis of doxorubicin accumulation and the indirect quantification of its DNA intercalation. Eur J Pharm Biopharm. 2010;76:514–524.
   PubMed Web of Science ®Google Scholar
• Banu H, Sethi DK, Edgar A, et al. Doxorubicin loaded polymeric gold nanoparticles targeted to human folate receptor upon laser photo thermal therapy potentiates chemotherapy in breast cancer cell lines. J Photochem Photobiol. 2015;149:116–128.
   Web of Science ®Google Scholar
• Shrivastav S, Bonar RA, Stone KR, et al. An in vitro assay procedure to test chemotherapeutic drugs on cells from human solid tumours. Cancer Res. 1980;40:4438–4442.
   PubMed Web of Science ®Google Scholar
• Czeczuga-Semeniuk E, Wolczynski S, Dabrowska M, et al. The effect of doxorubicin and retinoid on proliferation, necrosis and apoptosis in MCF-7 breast cancer cells. Folia Histochem Cytobiol. 2004;42(4):221–227.
   PubMed Web of Science ®Google Scholar
• Vavrova A, Jansova H, Mackova E, et al. Catalytic inhibitors of topoisomerase II differently modulate the toxicity of anthracyclines in cardiac and cancer cells. PLoS One. 2013;8(10):1–13.
   Web of Science ®Google Scholar
• El-Kareh WA, Secomb WT. Two-mechanism peak concentration model for cellular pharmacodynamics of doxorubicin. Neoplasia. 2005;7(7):705–713.
   PubMed Web of Science ®Google Scholar
• Rajagopalan S, Politi PM, Sinha BK, et al. Adriamycin-induced free radical formation in the perfused rat heart: implication for cardiotoxicity. Cancer Res. 1988;48:4766–4769.
   PubMed Web of Science ®Google Scholar
• Xu X, Persson HL, Richardson DR. Molecular pharmacology of the interaction of anthracyclines with iron. MolPharmacol. 2005;68(2):261–271.
   PubMed Web of Science ®Google Scholar
• Lanks KW, Gao J, Sharma T. Photodynamic enhancement of doxorubicin cytotoxicity. Cancer Chemother Pharmacol. 1994;35:17–20.
   PubMed Web of Science ®Google Scholar
• Chang W, Li J, Huang H, et al. Baicalein protects against doxorubicin-induced cardiotoxicity by attenuation of mitochondrial oxidant injury and JNK activation. J Cell Biochem. 2011;112(10):2873–2881.
   PubMed Web of Science ®Google Scholar
• Weinstein DM, Mihm MJ, Bauer JA. Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice. J Pharmacol Exp Ther. 2000;294:396–401.
   PubMed Web of Science ®Google Scholar
• Fogli S, Nieri P, Breschi MC. The role nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage. Faseb J. 2004;18:664–675.
   PubMed Web of Science ®Google Scholar
• Minotti G, Recalcati S, Mordente A, et al. The secondary alcohol metabolite of doxorubicin irreversibly inactivates aconitase/iron regulatory protein-1 in cytosolic fractions from human myocardium. FASEB J. 1998;12:541–552.
   PubMed Web of Science ®Google Scholar
• Clementi ME, Giardina B, Di Stasio E, et al. Doxorubicin-derived metabolites induce release of cytochrome C and inhibition of respiration on cardiac isolated mitochondria. Anticancer Res. 2003;23:2445–2450.
   PubMed Web of Science ®Google Scholar
• Lopes MA, Meisel A, Dirnagl U, et al. Doxorubicin induces biphasic neurotoxicity to rat cortical neurons. Neurotoxicology. 2008;29:286–293.
   PubMed Web of Science ®Google Scholar
• Kaur A, Kaur M, Kumar S, et al. Doxorubicin: a critical review of toxicity. Int J Appl Res Nat Prod. 2012;1:208–212.
   Google Scholar
• Zhang J, Huang Z, Dong L. Improving the tumor-specific delivery of doxorubicin in primary liver cancer, liver tumors, Julianov A (Ed)., ISBN: 978-953-51-0036-2, InTech 2012. Available from: http://www.intechopen.com/books/howtoreference/liver-tumors/improving-the-tumor-specific-delivery-of-doxorubicin-in-primary-liver-cancer
   Google Scholar
• Schimmel K, Richel D, Brink RVD, et al. Cardiotoxicity of cytotoxic drugs. Cancer Treat Rev. 2004;30:181–191.
   PubMed Web of Science ®Google Scholar
• Panda S, Kar A. Periplogenin-3-O-D-glucopyranosyl – (1->6) – D-glucopyaranosyl- – (1->4) – D-cymaropyranoside, isolated from aegle marmelosprotects doxorubicin induced cardiovascular problems and hepatotoxicity in rats. Cardiovasc Ther. 2009;27(2):108–116.
   PubMed Web of Science ®Google Scholar
• Dolmans EJGJD, Fukumura D, Jain KR. Photodynamic therapy for cancer. Nat Rev Cancer. 2003;3:380–387.
   PubMed Web of Science ®Google Scholar
• Nyokong T. Effects of substituents on the photochemical and photophysical properties of main group metal phthalocyanines. Coord Chem Rev. 2007;251:1707–1722.
   Web of Science ®Google Scholar
• Sakamoto K, Ohno-Okumura E. Synthesis and functional properties of phthalocyanines. Materials. 2009;2:1127–1180.
   Web of Science ®Google Scholar
• Fabris C, Soncin M, Miotto G, et al. Zn(II)-phthalocyanines as phototherapeutic agents for cutaneous diseases. Photosensitization of fibroblasts and keratinocytes. J Photochem Photobiol. 2006;83:48–54.
   Web of Science ®Google Scholar
• Tynga IM, Abrahamse H. Cell death pathways and phthalocyanine as an efficient agent for photodynamic cancer therapy. Int J Mol Sci. 2015;16:10228–10241.
   PubMed Web of Science ®Google Scholar
• Chidawanyika W, Ogunsipe A, Nyokong T. Synthesis and photophysics of new phthalocyanine derivatives of zinc, cadmium and mercury. New J Chem. 2007;31:377–384.
   Web of Science ®Google Scholar
• Nombona N, Nyokong T. Photophysical and photochemical studies of sulfur containing phthalocyanine derivatives in the presence of folic acid. Inorg Chim Acta. 2012;392:380–387.
   Web of Science ®Google Scholar
• Nemykin VN, Lukyanets EV. Synthesis of substituted phthalocyanines. Arkivoc. 2010;1:136–208.
   Google Scholar
• Kaya AA. Synthesis, characterization and thermal behavior of novel phthalocyanines bearing chalcone groups on peripheral positions. BulgChemCommun. 2015;47(3):844–848.
   Web of Science ®Google Scholar
• Sharman WM, Allen CM, van-Lier JE. Photodynamic therapeutics: basic principles and clinical applications. Ther Focus. 1999;4(11):507–517.
   Google Scholar
• Ramos AA, Nascimento BF, Souza MFT, et al. Photochemical and photophysical properties of phthalocyanines modified with optically active alcohols. Molecules. 2015;20:13575–13590.
   PubMed Web of Science ®Google Scholar
• Santosa V, Limantara L, Photodynamic therapy: new light in medicine world. Indo J Chem. 2008;82:279–291.
   Google Scholar
• Abrahamse H, Hamblin RM. New photosensitizers for photodynamic therapy. Biochem J. 2016;473:347–464.
   PubMed Web of Science ®Google Scholar
• Medina WSG, Santos NAG, Curti C, et al. Effects of zinc phthalocyaninetetrasulfonate-based photodynamic therapy on rat brain isolated mitochondria. Chem Biol Interact. 2009;179:402–406.
   PubMed Web of Science ®Google Scholar
• Castano AP, Mroz P, Wu MX, et al. Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model. Proc Natl Acad Sci. 2008;10514:5495–5500.
   PubMed Web of Science ®Google Scholar
• Korbelik M, Dougherty GJ. Photodynamic therapy mediated immune response against subcutaneous mouse tumors. Cancer Res. 1999;59:1941–1946.
   PubMed Web of Science ®Google Scholar
• Korbelik M, Sun J, Cecic I. Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. Cancer Res. 2005;65:1018–1026.
   PubMed Web of Science ®Google Scholar
• Kushibiki T, Hirasawa T, Okawa S, et al. Response of cancer cells induced by photodynamic therapy. J Healthc Eng. 2013;4(1):87–108.
   PubMed Web of Science ®Google Scholar
• Wagenpfeil S, Treiber U, Lehmer A. Statistical analysis of combined dose effects for experiments with two agents. Artif Intell Med. 2006;37(1):65–71.
   PubMed Web of Science ®Google Scholar
• Nahabedian MY, Cohen RA, Contino MF, et al. Combination cytotoxic chemotherapy with cisplastin or doxorubicin and photodynamic therapy in murine tumors. J Natl Cancer Inst. 1998;80:739–746.
   Google Scholar
• Canti G, Nicolin A, Cubeddu R, et al. Antitumor efficacy of the combination of photodynamic therapy and chemotherapy in murine tumors. Cancer Lett. 1998;125:39–44.
   PubMed Web of Science ®Google Scholar
• Peterson CM, Lu JM, Sun Y, et al. Combination chemotherapy and photodynamic therapy with N-(2-hydroxypropyl) methacrylamide copolymer-bound anticancer drugs inhibit human ovarian carcinoma heterotransplanted in nude mice. Cancer Res. 1996;56:3980–3985.
   PubMed Web of Science ®Google Scholar
• Postiglione I, Chiaviello A, Palumbo G. Enhancing photodynamic therapy efficacy by combination therapy: dated, current and oncoming strategies. Cancers. 2011;3:2597–2629.
   PubMedGoogle Scholar
• Kirveliene V, Grazeliene G, Dabkeviciene D, et al. Schedule-dependent interaction between doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo. Cancer Chemother Pharmacol. 2006;57:65–72.
   PubMed Web of Science ®Google Scholar
• Zakaria S, Gamal-Eldeen AM, El-Daly SM, et al. Synergistic apoptotic effect of Doxil® and aminolevulinic acid-based photodynamic therapy on human breast adenocarcinoma cells. Photodiagnosis Photodynther. 2014;11:227–238.
   PubMed Web of Science ®Google Scholar
• Diez B, Ernst G, Teijo MJ, et al. Combined chemotherapy and ALA-based photodynamic therapy in leukemic murine cells. Leuk Res. 2012;36:1179–1184.
   PubMed Web of Science ®Google Scholar
• De Freitas LM, Serafim RB, De Sousa JF, et al. Photodynamic therapy combined to cisplatin potentiates cell death responses of cervical cancer cells. BMC Cancer. 2017;17:123.
   PubMed Web of Science ®Google Scholar
• Ruiz-Gonzalez R, Milan P, Bresoli-Obach R, et al. Photodynamic synergistic effect of pheophorbidea and doxorubicin in combined treatment against tumoral cells. Cancers. 2017;9:18.
   Web of Science ®Google Scholar